Shares of Blend Labs, Inc. (BLND) plummeted 11.54% in the pre-market trading session on Friday, following a price target cut by UBS analysts.
UBS reduced its price target for Blend Labs from $4 to $3.50, maintaining a Neutral rating on the stock. This downward revision in the price target appears to have triggered a significant sell-off in the company's shares, as investors reacted cautiously to the news.
Despite the broader analyst consensus of an "Overweight" rating and a mean price target of $5.37, according to FactSet data, UBS's price target cut seems to have weighed heavily on investor sentiment, leading to the substantial pre-market decline.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.